Citations

Clear

1444 citation(s) found for "Petersen, Ronald".

Subtle gait changes in patients with REM sleep behavior disorder
Boot, Brendon , Christianson, Teresa J., Ferman, Tanis J. , Bieniek, Kevin F. , Hollman, John H. , Roberts, Rosebud O., Mielke, Michelle M. , Petersen, Ronald C. , McDade, Eric M, McDade, Eric , Pankratz, V. Shane , Boeve, Bradley F. , Knopman, David S. , Mielke, Michelle M , Hollman, John , Ferman, Tanis J

Mayo Clinic

Movement Disorders | October 15, 2013 | Volume: 28 | Issue: 13 | Pages: 1847-1853

10.1002/mds.25653 | PMID 24130124 Get It

ABSTRACT Many people with rapid eye movement (REM) sleep behavior disorder (RBD) have an underlying synucleinopathy, the most common of which is Lewy body disease. Identifying additional abnormal clinical features may help in identifying those at greater risk of evolving to a more severe syndrome. Because gait disorders are common in the synucleinopathies, early abnormalities in gait in those with RBD could help in identifying those at increased risk of developing overt parkinsonism and/or cognitive impairment. We identified 42 probable RBD subjects and 492 controls using the Mayo Sleep Questionnaire and assessed gait velocity, cadence, and stride dynamics with an automated gait analysis system. Cases and controls were similar in age (79.9 ± 4.7 and 80.1 ± 4.7, P = 0.74), Unified Parkinson's Disease Rating Scale Part III (UPDRS) score (3.3 ± 5.5 and 1.9 ± 4.1, P = 0.21) and Mini–Mental State Examination scores (27.2 ± 1.9 and 27.7 ± 1.6, P = 0.10). A diagnosis of probable RBD was associated with decreased velocity (−7.9 cm/s; 95% confidence interval [CI], −13.8 to −2.0; P < 0.01), cadence (−4.4 steps/min; 95% CI, −7.6 to −1.3; P < 0.01), significantly increased double limb support variability (30%; 95% CI, 6–60; P = 0.01), and greater stride time variability (29%; 95% CI, 2–63; P = 0.03) and swing time variability (46%; 95% CI, 15–84; P < 0.01). Probable RBD is associated with subtle gait changes prior to overt clinical parkinsonism. Diagnosis of probable RBD supplemented by gait analysis may help as a screening tool for disorders of α‐synuclein. © 2013 International Parkinson and Movement Disorder Society
P1–248: Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics
Persson, Xuan‐Mai, Petersen, Ronald C. , Trushina, Eugenia , Dutta, Tumpa , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_6 | Pages: No page available

10.1016/j.jalz.2013.05.472 Get It

IC‐P‐089: FDG‐PET and PiB‐PET imaging in asymptomatic at‐risk carriers of a novel octapeptide repeat insertion in PRNP
Lowe, Val J. , Przybelski, Scott A. , Weigand, Stephen D. , Spychalla, Anthony J., Jones, David, Kumar, Neeraj , Rademakers, Rosa , Petersen, Ronald, Parisi, Joseph E. , Boeve, Bradley F. , Kantarci, Kejal , Vemuri, Prashanthi , McDade, Eric , Baker, Matthew , Knopman, David S. , Petersen, Ronald, Dickson, Dennis W. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2013.05.086 Get It

IC‐P‐067: Rates of atrophy differ across pathologically defined subtypes of Alzheimer's disease: A longitudinal MRI study
Whitwell, Jennifer L. , Murray, Melissa E. , Gunter, Jeffrey L. , Spychalla, Anthony J., Petersen, Ronald C. , Josephs, Keith A. , Dickson, Dennis W. , Senjem, Matthew L. , Jack, Clifford R. , Murray, Melissa E

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2013.05.064 Get It

IC‐P‐066: Structural and functional connectivity in the logopenic variant of primary progressive aphasia and a comparison with dementia of the Alzheimer's type
Whitwell, Jennifer , Duffy, Joseph, Jones, David, Wille, Samantha, Petersen, Ronald, Josephs, Keith A. , Strand, Edythe A. , Machulda, Mary M. , Jones, David, Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2013.05.063 Get It

P2–086: MRS differentiates people with MCI who progress to dementia with Lewy bodies from people who progress to Alzheimer's disease
Zhang, Bing , Maroney‐Smith, Mandie, Petersen, Ronald C. , Ferman, Tanis J. , Boeve, Bradley F. , Smith, Glenn E. , Knopman, David S. , Jack, Clifford R. , Kantarci, Kejal

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_9 | Pages: No page available

10.1016/j.jalz.2013.05.729 Get It

O4–02–05: Combinations of amyloid and neurodegeneration biomarkers have a differential impact on cognition
Wiste, Heather J. , Weigand, Stephen D. , Roberts, Rosebud O., Lowe, Val J. , Petersen, Ronald C. , Knopman, David S. , Jack, Clifford R. , Vemuri, Prashanthi , Mielke, Michelle M. , Machulda, Mary M. , Boeve, Bradley F. , Kantarci, Kejal

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2013.04.344 Get It

P1–334: Development and implementation of the National Alzheimer's Prevention Registry
High, Nellie, Aisen, Paul , Albert, Marilyn, Brown, Kyle, Comer, Meryl, Petersen, Ronald C. , Strobel, Gabrielle, Weiner, Michael W. , Tariot, Pierre N. , Reiman, Eric M. , Langbaum, Jessica B. S. , Cummings, Jeffrey L. , Manly, Jennifer J. , Sperling, Reisa Anne

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2013.05.560 Get It